Category: Uncategorised

A kidney stone can cause severe pain, nausea, blood in the urine and an urgent need for treatment. When a stone is unlikely to pass naturally, two common minimally invasive options are ureteroscopy versus shockwave lithotripsy. Both treatments can be highly effective, but they work differently and suit different stone sizes, locations and clinical circumstances.

The right procedure is not simply a matter of preference. CT imaging, stone position, stone density, anatomy, symptoms, infection risk and previous stone treatment all influence the decision. A specialist urological assessment helps determine the approach most likely to clear the stone safely and efficiently.

Understanding ureteroscopy versus shockwave lithotripsy

Shockwave lithotripsy, often called ESWL or SWL, uses focused sound waves generated outside the body to break a stone into smaller fragments. The fragments then pass through the urinary tract over the following days or weeks. No instrument needs to pass into the urinary tract to reach the stone.

Ureteroscopy involves passing a fine telescope through the urethra and bladder, then into the ureter or kidney. The surgeon locates the stone directly and usually breaks it with a laser. Stone pieces may be removed with a small basket, or reduced to fine fragments that can pass naturally.

Both procedures aim to relieve obstruction, prevent recurrent pain and reduce the risk of infection or kidney damage. Their key difference is that ureteroscopy provides direct access to the stone, while shockwave lithotripsy treats it from outside the body.

When shockwave lithotripsy may be suitable

Shockwave lithotripsy is often considered for selected stones in the kidney or upper ureter, particularly when they are relatively small and visible on imaging. It can be an appealing option because there are no incisions and no instruments are passed through the urinary tract.

Treatment is usually performed as a day procedure. Depending on the hospital and individual circumstances, sedation or a general anaesthetic may be used. During treatment, imaging is used to target the stone and several thousand shockwaves are delivered over a set period.

The main advantage is its non-invasive nature. Recovery is often quick, and many people return to light activities within a short time. Some discomfort, bruising, blood in the urine and passage of stone fragments are common afterwards. Pain can occur as fragments travel through the ureter, sometimes called colic.

Its limitation is that successful fragmentation does not always mean immediate stone clearance. Larger, harder or unfavourably positioned stones may not break adequately. A second shockwave session or a subsequent ureteroscopy may be required. Stone-free rates can therefore be lower than with ureteroscopy in some situations.

Shockwave lithotripsy may be less appropriate where there is significant obstruction, an untreated urinary infection, a bleeding disorder, pregnancy, certain anatomical factors or a stone that is difficult to target. Stones with higher density on CT are also less likely to fragment effectively.

When ureteroscopy may be the better option

Ureteroscopy is frequently used for stones in the ureter, especially stones causing persistent pain, obstruction or infection. It is also effective for many kidney stones, including stones that are dense, have not responded to shockwave treatment or are in a location less favourable for shockwaves.

Because the surgeon can see the stone directly, ureteroscopy offers a high likelihood of treating the stone in one procedure. Laser technology allows controlled fragmentation, and larger pieces can often be removed at the same time. This makes ureteroscopy particularly useful when prompt, reliable clearance is needed.

The procedure is generally performed under general anaesthetic. It is usually day surgery, although admission may be needed if there is infection, complex stone disease or another medical concern. Most patients have some burning when passing urine, urinary frequency or mild blood in the urine for a short period afterwards.

A temporary ureteric stent is commonly placed after ureteroscopy. This is a soft internal tube that supports drainage from the kidney to the bladder while swelling settles. A stent can cause urinary urgency, frequency, flank discomfort or discomfort during activity. It is removed after a period determined by the surgeon, often in rooms or by a short follow-up procedure.

Ureteroscopy is more invasive than shockwave lithotripsy, but it is still a minimally invasive procedure. It avoids skin incisions and usually provides a more immediate solution for stones that are unlikely to respond well to shockwaves.

How stone features affect the decision

Stone size is one of the first considerations. Smaller stones may be suitable for either procedure, depending on location and symptoms. As stones become larger, ureteroscopy often offers more predictable clearance. Very large kidney stones may require a different operation altogether, such as percutaneous stone surgery.

Location matters just as much. Stones in the lower ureter can be difficult to target with shockwaves because of surrounding pelvic bones. Ureteroscopy may be preferred in this setting. Stones in the kidney may be suitable for shockwaves when they are clearly visible and positioned in a way that allows fragments to drain effectively.

The stone’s composition can also be relevant. Harder stones, including those with high density on CT, can be resistant to shockwave treatment. Ureteroscopy with laser fragmentation may be more effective in these cases. A previous stone analysis, when available, can assist with longer-term prevention planning.

Body habitus and individual anatomy can affect shockwave accuracy and energy delivery. A stone that is further from the skin surface or difficult to identify on imaging may be less suitable for lithotripsy. Previous urinary tract surgery, narrowing of the ureter and kidney anatomy are also considered before recommending either procedure.

Recovery, risks and practical differences

Recovery varies between patients, but shockwave lithotripsy often involves less immediate urinary irritation. The trade-off is that stone fragments can pass unpredictably over time, and further treatment may be needed. Patients may be asked to strain their urine to collect fragments for analysis and to maintain adequate fluid intake unless advised otherwise.

After ureteroscopy, the initial recovery can be more noticeable, particularly when a stent is in place. However, the stone is usually treated directly at the time of surgery. For people who need rapid relief from an obstructing ureteric stone, that degree of control can be an important benefit.

Both treatments carry risks, although serious complications are uncommon. These include urinary tract infection, bleeding, persistent stone fragments and the need for further procedures. Ureteroscopy has a small risk of ureteric injury or stricture. Shockwave lithotripsy can occasionally cause a build-up of fragments in the ureter, which may obstruct urine flow and require further intervention.

An infected obstructed kidney is a urological emergency. Fever, chills, worsening pain, vomiting or feeling generally unwell in the setting of a known stone require urgent medical assessment. In this circumstance, drainage of the kidney with a ureteric stent or nephrostomy may be needed before definitive stone treatment can proceed.

Questions to discuss with your urologist

A useful consultation focuses on the features of your individual stone rather than a general comparison of procedures. Ask whether the stone is likely to pass, whether it is causing obstruction, and what treatment offers the best chance of becoming stone-free in one session.

It is also reasonable to discuss whether a stent is likely, how long it would remain in place, expected time away from work or usual activities, and the chance that another procedure may be necessary. If you have recurrent stones, metabolic assessment and stone analysis can help identify measures to reduce future episodes.

For patients across Adelaide and regional South Australia, specialist assessment allows treatment to be planned around the stone, symptoms and overall health. The most suitable approach is the one that safely clears the stone while minimising disruption and avoiding unnecessary repeat treatment.

A partial nephrectomy removes a kidney tumour or abnormal area while preserving as much healthy kidney tissue as possible. This partial nephrectomy recovery review explains the practical milestones patients can expect after surgery, including what may feel normal, what requires a call to the surgical team, and why recovery time differs between individuals.

Partial nephrectomy may be performed using robotic or laparoscopic techniques, or as an open operation when the location, size or complexity of the kidney mass requires it. The surgical approach influences the incision, early discomfort and length of admission, but the aim of recovery remains the same: safe healing, gradual return to activity and ongoing monitoring of kidney function and imaging results.

The first days after partial nephrectomy

Most patients are admitted to hospital for a short period after minimally invasive surgery. The exact duration depends on the operation, pain control, kidney function, mobility and whether any additional monitoring is required. An open operation can involve a longer hospital stay and a slower early recovery.

Immediately after surgery, patients may have an intravenous drip, a urinary catheter and, in some cases, a surgical drain. These are temporary measures used to monitor urine output, fluid balance and the surgical area. The catheter is commonly removed once it is safe to do so, allowing the patient to pass urine normally before discharge.

Pain is expected, particularly around incision sites and in the abdominal or flank region. Shoulder-tip discomfort can also occur after laparoscopic or robotic surgery because of the gas used to create working space during the procedure. This usually settles over several days. Pain relief is tailored to the individual and often progresses from stronger medication in hospital to simple oral pain relief at home.

Early mobilisation is an important part of care. Walking with assistance on the day of surgery or the following day helps reduce the risk of blood clots, improves lung function and encourages bowel activity. Patients should move regularly but avoid trying to do too much too soon.

Partial nephrectomy recovery review: the first two weeks

The first fortnight at home is usually focused on rest, short walks, wound care and rebuilding appetite and energy. Fatigue is common. Even when small incisions have been used, partial nephrectomy is significant surgery, and the body needs time to recover from both the operation and anaesthetic.

It is common to experience mild bruising, swelling or tenderness around the wounds. Some patients notice a pulling sensation when standing upright, coughing or changing position. This should gradually improve rather than worsen. A small amount of blood staining in the urine can occur early in recovery, but persistent heavy bleeding, clots or difficulty passing urine should be assessed promptly.

Constipation is also common after surgery due to anaesthetic, reduced movement and opioid pain medicines. Drinking adequate fluids, walking regularly and using bowel medication if prescribed can help. Straining should be avoided, particularly in the early weeks while the abdominal wall and internal surgical site are healing.

Wounds should be kept clean and managed according to the discharge instructions. Showering is commonly permitted, but bathing, swimming and soaking the wounds may need to wait until healing is established. Redness spreading from the wound, increasing heat, pus, wound separation or a fever should be reported to the treating team.

Driving should not resume until the patient is comfortable, mobile and able to perform an emergency stop safely without pain or restriction. This often takes at least one to two weeks after minimally invasive surgery, and longer after open surgery. Patients should also check the requirements of their insurer and avoid driving while taking sedating pain medication.

Activity, work and exercise after surgery

Recovery is not measured only by the appearance of the incisions. The kidney has been operated on internally, and heavier physical activity needs to be reintroduced carefully. Short walks can be increased day by day according to comfort. This is preferable to prolonged bed rest and helps restore stamina without placing excessive strain on the abdomen.

Heavy lifting, gym work, vigorous cycling, running and contact sports are generally restricted for several weeks. The precise timeframe depends on the surgical approach and the surgeon’s instructions. Patients whose work involves manual handling, climbing, operating machinery or physically demanding duties may need a longer period away from work than those with desk-based roles.

Many patients return to office-based or light duties within two to four weeks after robotic or laparoscopic surgery, provided pain and fatigue are improving. Recovery following open partial nephrectomy can take longer. A planned return to work may be staged, particularly for patients travelling long distances or managing demanding regional work commitments.

Sexual activity can usually resume when the patient feels comfortable and is no longer limited by pain or fatigue. There is no benefit in rushing this stage of recovery. If there are specific concerns about exercise, travel or a planned return to work, these should be discussed before discharge or at the post-operative appointment.

Eating, drinking and protecting kidney health

An appetite may be reduced for several days after surgery. Small, regular meals and adequate hydration are usually easier than forcing large meals. Unless a patient has been given specific fluid restrictions for another medical reason, maintaining good fluid intake supports recovery and helps prevent constipation.

There is not one universal diet after partial nephrectomy. Some patients will have pre-existing kidney disease, high blood pressure, diabetes or other conditions that require individual dietary advice. In general, a balanced diet with adequate protein for healing, fruit and vegetables, and limited highly processed foods is appropriate. Alcohol should be avoided while taking opioid pain medication and approached cautiously until recovery is well established.

Preserving kidney tissue is a key benefit of partial nephrectomy, but kidney function still requires follow-up. Blood tests may be arranged to assess creatinine and estimated kidney function. Patients should tell their treating doctor about all medicines and supplements, particularly anti-inflammatory medicines, as some can affect kidney function or increase bleeding risk in the peri-operative period.

Follow-up after partial nephrectomy

A follow-up appointment allows the surgeon to review wound healing, pathology findings and the plan for future imaging. The pathology report provides the definitive information about the removed tissue, including whether a tumour was present, its type and other features that guide surveillance.

Follow-up scans are an essential part of care after surgery for a kidney mass. Their timing and frequency are individualised according to the pathology, the complexity of the operation and the patient’s wider health. Surveillance is not a sign that something has gone wrong. It is a structured way of monitoring the treated kidney, the other kidney and overall health after surgery.

Bring any questions about pain, return to work, medication or imaging to this appointment. It is also helpful to mention symptoms that may seem minor, such as ongoing nausea, marked fatigue or urinary changes. Clear communication allows the recovery plan to be adjusted where needed.

When to seek urgent medical advice

Patients should contact their surgical team, GP or seek urgent assessment if they develop fever or chills, worsening rather than improving pain, persistent vomiting, heavy bleeding in the urine, inability to pass urine, chest pain, shortness of breath, calf swelling, or signs of wound infection. These symptoms do not always indicate a serious complication, but they should not be managed by waiting at home.

A sudden decline in general wellbeing is also worth assessing, especially in the first few weeks. Patients who live alone or travel back to a regional area should have a clear discharge plan, appropriate contact details and practical support available during the early recovery period.

Recovery after partial nephrectomy is usually progressive rather than linear. Some days will feel more tiring than others, particularly after increased activity. Following the surgical instructions, attending planned reviews and allowing enough time for healing gives patients the best foundation for a safe return to normal routines.

For men whose enlarged prostate is disrupting sleep, slowing the urinary stream or causing repeated urinary retention, the practical question is whether treatment will provide lasting relief. HoLEP surgery outcomes are generally very favourable for appropriately selected patients, particularly where urinary symptoms are caused by benign prostatic enlargement and medicines are no longer effective or suitable.

HoLEP, or Holmium Laser Enucleation of the Prostate, is a minimally invasive operation used to remove the obstructing portion of the prostate. Rather than simply creating a channel through the gland, the surgeon separates and removes the enlarged inner prostate tissue causing blockage. The tissue is then sent for laboratory examination.

What HoLEP is designed to improve

The prostate commonly enlarges with age. When it narrows the urethra, it can lead to a weak or intermittent stream, straining, incomplete bladder emptying, urgency, frequent urination and waking overnight to pass urine. In more advanced cases, men may experience recurrent urinary retention, urinary tract infections, bladder stones or declining kidney function related to obstruction.

HoLEP aims to relieve this obstruction. It may be considered for a wide range of prostate sizes, including substantially enlarged prostates that might otherwise require open surgery or a more extensive operation. Whether HoLEP is the most suitable approach depends on prostate anatomy, the severity of symptoms, bladder function, medical history, blood-thinning medication and previous prostate procedures.

HoLEP surgery outcomes for urinary symptoms

Urine flow and bladder emptying

Most patients notice a stronger urinary stream after the catheter has been removed and the early healing period has passed. The amount of urine left in the bladder after voiding often improves significantly because the physical blockage has been removed.

Not every symptom improves at the same pace. A slow stream and straining are commonly related directly to obstruction and may improve early. Urgency, frequency and nocturia can take longer, particularly when the bladder has been working against obstruction for years. An overactive or poorly functioning bladder may continue to cause symptoms even after technically successful surgery.

This distinction is important during consultation. Investigations such as urine testing, ultrasound measurement of residual urine, flow studies and, in selected cases, urodynamic testing can help clarify whether symptoms are mainly caused by prostate obstruction, bladder dysfunction or a combination of both.

Durability of the result

A key advantage of HoLEP is that it removes a substantial amount of the obstructing prostate tissue. Long-term studies have shown durable improvement in urinary flow and symptom scores, with a low likelihood of requiring further surgery for recurrent obstruction.

No procedure can guarantee that urinary symptoms will never return. Bladder changes, urethral scarring, infection, neurological conditions and other medical issues can affect urinary function later. However, for men with obstruction from benign enlargement, HoLEP is regarded as a durable surgical option.

Medication after surgery

Many men no longer require medicines previously used to improve urinary flow after a successful HoLEP procedure. This decision should be made with the treating urologist, as some medicines may have been prescribed for other urinary or medical reasons. Bladder-directed medication may still be appropriate for patients with persistent urgency or frequency during recovery.

Recovery after HoLEP

HoLEP is performed under anaesthetic in hospital. A urinary catheter is usually required immediately after surgery to allow bladder drainage and irrigation. It is commonly removed within one to two days, although the timing varies according to urine colour, bleeding, bladder function and individual circumstances.

Blood in the urine is expected in the early period and should gradually settle. Some men see intermittent blood or small clots around one to three weeks after surgery, when internal healing tissue separates. Maintaining good fluid intake, unless otherwise advised for another medical condition, helps keep the urine clear.

Burning with urination, urgency and frequency are also common during the first weeks. These symptoms usually improve as the surgical area heals. Heavy lifting, strenuous exercise, cycling and activities that increase pelvic pressure are generally avoided for a period advised by the surgeon. Return to office-based work may occur sooner than return to physically demanding work.

Recovery is not identical for every patient. Men who required a catheter before surgery, had longstanding retention or have significant bladder dysfunction may require more time before they establish a satisfactory urinary pattern.

Continence outcomes

Temporary leakage is one of the most important issues to discuss before HoLEP. Some men experience urgency leakage or stress leakage, particularly with coughing, lifting or standing from a chair, after catheter removal. This occurs because the urinary sphincter and bladder are adapting to a changed outlet after long-term obstruction.

For most patients, control improves over the following weeks to months. Pelvic floor muscle exercises can support recovery and may be recommended before and after surgery. Persistent or severe leakage is less common but requires review, as it may need further assessment and targeted management.

Age, prostate size, existing bladder dysfunction, prior prostate surgery and pre-operative continence all influence individual risk. A specialist discussion should focus on the expected outcome in the context of the individual patient, rather than a single percentage drawn from a study population.

Ejaculatory changes and fertility

HoLEP commonly changes ejaculation. Because prostate tissue at the bladder outlet is removed, semen may pass backwards into the bladder during orgasm rather than out through the penis. This is known as retrograde ejaculation and is usually permanent after the procedure.

It does not cause harm, but it is a significant consideration for men who wish to father children naturally. Fertility plans should be discussed before surgery so that appropriate options can be considered. Patients should also raise any concerns about sexual wellbeing during consultation, as these form part of informed surgical decision-making.

Risks that can affect HoLEP outcomes

HoLEP is an established procedure, but it remains surgery and carries risks. Bleeding, infection, temporary difficulty passing urine, bladder irritation and the need for a short period of catheter drainage can occur. Less commonly, a urethral stricture or narrowing at the bladder neck may develop later and require treatment.

Very occasionally, residual prostate tissue, bleeding or another technical issue may require an additional procedure. The removed tissue is examined by a pathologist. While HoLEP is performed for benign enlargement, laboratory analysis can sometimes identify an unexpected prostate abnormality that requires further discussion.

The experience of the surgeon, the hospital setting and careful pre-operative assessment all contribute to procedural safety. Blood-thinning medicines, heart and lung conditions, diabetes, prior pelvic treatment and a history of urinary retention need to be considered when planning surgery.

Making sense of results at follow-up

Follow-up is not simply a check of the urinary stream. It is an opportunity to assess healing, continence, bladder emptying, infection symptoms and the pathology result. Symptom improvement should be judged over time, not solely in the first few days after catheter removal when urgency and irritation can be prominent.

Patients should seek earlier medical advice if they cannot pass urine, develop fever or chills, have worsening pain, pass large clots, or experience heavy bleeding that does not improve with rest and fluids. These symptoms may indicate a complication requiring prompt assessment.

For patients considering surgery for an enlarged prostate, the most useful consultation is one that matches the procedure to the cause of their symptoms and sets realistic expectations for recovery. A careful assessment can clarify whether HoLEP offers the right balance of symptom relief, durability and recovery for their circumstances.

Upper tract urothelial cancer is uncommon, but it requires careful assessment because it can arise anywhere along the lining of the kidney drainage system and ureter. Robotic nephroureterectomy for urothelial cancer is a specialist operation used when removal of the affected kidney, ureter and a small section of bladder is the safest and most appropriate treatment.

The decision to proceed is individual. It depends on the tumour’s grade and location, imaging findings, kidney function, previous bladder cancer, overall health and whether there is evidence that disease has spread. A urologist will discuss the expected benefit of surgery alongside the alternatives and the recovery required.

What is upper tract urothelial cancer?

Urothelial cells line the inside of the bladder, ureters and the collecting system of each kidney. Cancer arising from these cells in the kidney drainage system or ureter is called upper tract urothelial carcinoma.

Blood in the urine is a common presenting symptom, although it is not always visible. Some patients have flank discomfort, recurrent urinary tract symptoms or an abnormality found during imaging for another reason. Others have no symptoms. These signs can have causes other than cancer, but visible blood in the urine should always be assessed promptly.

Investigations commonly include a CT urogram, urine testing and cystoscopy to inspect the bladder. In selected cases, ureteroscopy allows the urologist to pass a fine telescope into the ureter or kidney drainage system to inspect the lesion and obtain a biopsy. Staging scans may also be needed before treatment is planned.

When is robotic nephroureterectomy recommended?

For high-risk, invasive or larger upper tract urothelial cancers, radical nephroureterectomy is generally the standard surgical treatment. This involves removal of the kidney, the full length of the ureter and a cuff of bladder where the ureter enters it. Leaving the lower end of the ureter behind can increase the risk of cancer recurring there, which is why complete removal is important.

Robotic nephroureterectomy may be recommended when a minimally invasive approach is suitable for the individual patient and the tumour can be safely treated this way. The robot does not perform surgery independently. It is a surgical platform controlled entirely by the surgeon, providing magnified three-dimensional vision and instruments designed for precise movement within the abdomen and pelvis.

Not every upper tract tumour requires removal of the whole kidney and ureter. Kidney-sparing treatment may be considered for selected low-risk tumours, small lesions or patients with reduced function in the opposite kidney. Options may include endoscopic laser treatment, segmental ureteric surgery or local treatment delivered into the upper urinary tract. These approaches preserve renal tissue but usually require closer surveillance and, in some circumstances, repeat procedures.

Conversely, open surgery may be preferable where there has been extensive previous abdominal surgery, complex anatomy, bulky disease or another factor that makes a robotic approach less appropriate. The surgical method is chosen for cancer control and patient safety, not for the technology alone.

How the robotic procedure is performed

A robotic nephroureterectomy is performed under general anaesthetic in hospital. Several small abdominal incisions are made to place the camera and robotic instruments. The kidney and ureter are carefully separated from surrounding structures, with blood vessels controlled and divided. The surgeon then removes the ureter down to its entry into the bladder, together with a small bladder cuff.

The specimen is removed through a small extension of one incision, usually in the lower abdomen. A urinary catheter is left in place while the bladder repair heals. Depending on the operation and the bladder closure, it may remain for several days to around two weeks. Some patients require a bladder X-ray study before the catheter is removed.

Lymph nodes may be removed if imaging, tumour features or the location of disease indicate this is appropriate. Lymph node dissection can provide staging information and may have a role in managing higher-risk disease, although the extent required varies between patients.

Potential benefits and limitations of a robotic approach

Compared with a traditional open incision, a robotic approach can offer smaller wounds, less postoperative pain, reduced blood loss and a shorter hospital stay for suitable patients. It can also assist with the precise pelvic dissection needed to remove the lower ureter and bladder cuff.

These benefits are not guaranteed. Recovery is influenced by age, general fitness, kidney function, the complexity of surgery and whether additional procedures are required. The most important outcome is complete and safe cancer surgery with appropriate pathological assessment. In some cases, a planned robotic procedure may need to be converted to an open operation if this is safer.

Risks to discuss before surgery

All major surgery carries risks. Your surgeon and anaesthetist will discuss your individual risk profile, including medicines such as blood thinners and any heart, lung or kidney conditions. Potential complications of nephroureterectomy include:

• bleeding that may require transfusion or a further procedure;
• infection, wound complications or a urine leak from the bladder repair;
• injury to nearby structures, including bowel or blood vessels;
• blood clots in the legs or lungs, chest complications and risks related to anaesthesia;
• reduced overall kidney function after removal of one kidney; and
• the possibility of cancer recurrence in the bladder, remaining urinary tract or elsewhere.

Most people can live well with one kidney, provided the remaining kidney is healthy. Before surgery, kidney function is measured and the opposite kidney is reviewed on imaging. This is particularly relevant for patients with diabetes, high blood pressure, previous kidney disease or impairment affecting both kidneys.

Hospital stay and recovery at home

Hospital stay after uncomplicated robotic surgery is often a few days, although it may be longer if recovery is slower or there are medical issues requiring observation. Early walking, breathing exercises, adequate pain relief and prevention of constipation are all part of postoperative care.

At home, fatigue is expected in the first few weeks. Gentle daily activity is encouraged, but heavy lifting, strenuous exercise and driving should wait until you are comfortable, mobile and no longer taking sedating pain medicine. The timing varies, though many patients need several weeks before resuming normal routines and longer for physically demanding work.

Contact the treating team promptly if you develop fever, worsening abdominal pain, persistent vomiting, increasing wound redness, calf swelling, chest pain, shortness of breath, heavy blood in the urine or problems with the catheter. Clear written discharge instructions should cover catheter care, medications, activity restrictions and who to call after hours.

Pathology, bladder treatment and surveillance

The final pathology report determines the tumour grade, depth of invasion, surgical margins and whether lymph nodes contain cancer. These results guide the next stage of care. Some patients with higher-risk features may be referred to a medical oncologist to discuss systemic treatment, either before or after surgery depending on the clinical situation and kidney function.

Urothelial cancer can recur in the bladder even after the affected kidney and ureter have been removed. For this reason, cystoscopy remains an important part of follow-up. In selected patients, a single dose of chemotherapy placed into the bladder soon after surgery may reduce the chance of a later bladder recurrence. This is only used when it is safe to do so and there is no concern about leakage from the bladder repair.

Follow-up usually includes regular cystoscopy, urine tests, kidney function blood tests and imaging. The schedule depends on the original tumour’s risk category and pathology. Ongoing surveillance is a central part of treatment, rather than an optional extra after surgery.

Planning specialist care

A consultation for suspected or confirmed upper tract urothelial cancer should bring together imaging, biopsy results where available, medication lists and relevant medical history. At Urology Health Adelaide, discussion of robotic surgery focuses on whether it is appropriate for the cancer and the patient, as well as the practical details of hospital treatment and recovery.

When facing a diagnosis of upper tract urothelial cancer, timely specialist assessment helps turn a complex decision into a clear treatment plan, with surgery and follow-up tailored to the findings that matter most.

A weak stream, repeated night-time trips to the bathroom and the feeling that the bladder never fully empties can significantly affect daily life. When medication no longer provides adequate relief, the decision between TURP vs robotic simple prostatectomy usually comes down to the size and shape of the prostate, the degree of obstruction, overall health and the outcomes that matter most to the individual.

Both procedures treat urinary obstruction caused by benign prostatic enlargement, also called benign prostatic hyperplasia or BPH. They are not treatments for prostate cancer. The aim is to remove or reduce the obstructing inner part of the prostate so urine can pass more freely through the urethra.

Why an enlarged prostate can require surgery

The prostate sits below the bladder and surrounds the urethra, the tube that carries urine out of the body. As the prostate enlarges, it can narrow this passage and make bladder emptying more difficult. Symptoms may include a slow or interrupted stream, straining, urgency, frequency, nocturia, recurrent urinary infections or urinary retention.

Surgery may be considered when symptoms remain troublesome despite medication, when a man cannot pass urine without a catheter, or when obstruction is affecting bladder or kidney function. Bladder stones, recurrent visible bleeding in the urine and repeated urinary infections can also be reasons to discuss a procedure.

Before recommending surgery, a urologist assesses symptoms, urine flow, residual urine left in the bladder after voiding, prostate size and relevant blood tests. Imaging and cystoscopy may be required in selected cases. This evaluation is essential because similar urinary symptoms can have more than one cause.

TURP vs robotic simple prostatectomy: the key difference

A transurethral resection of the prostate, or TURP, is performed through the urethra. A narrow telescope is passed through the penis to the prostate, and the surgeon removes obstructing prostate tissue in small sections. There are no external surgical cuts. Modern TURP is commonly performed using bipolar energy, which allows tissue removal and control of bleeding with saline irrigation.

Robotic simple prostatectomy is a minimally invasive abdominal operation performed using robotic surgical instruments through several small incisions. The surgeon removes the enlarged inner portion of the prostate, often called the adenoma, while leaving the outer capsule in place. Despite the name, it is a major operation and is distinct from robotic radical prostatectomy, which removes the entire prostate for cancer treatment.

The central practical difference is the amount of tissue each operation is designed to address. TURP is a well-established option for many small to moderately enlarged prostates. Robotic simple prostatectomy is generally considered for substantially enlarged glands, particularly where a transurethral procedure may be less efficient or may need to be staged.

When TURP may be the appropriate procedure

TURP has been used for decades because it provides reliable relief of obstruction for appropriately selected men. It avoids abdominal incisions and is often suitable when the prostate is not excessively large. It can also be a sensible option for patients whose anatomy and health profile favour a shorter endoscopic operation.

After TURP, a urinary catheter is usually left in place temporarily to allow the bladder to drain and the urine to clear. Many patients stay in hospital overnight, although this varies according to recovery, bleeding and other medical considerations. Burning when passing urine, urinary frequency and small amounts of blood in the urine can occur during early healing.

TURP removes tissue from within the prostate but does not remove all prostate tissue. Symptoms commonly improve substantially, although the degree of improvement depends on bladder function as well as the obstruction itself. In some men, prostate tissue can regrow over time and further treatment may eventually be required.

For large prostates, TURP can take longer and may carry a higher risk of bleeding or incomplete removal of obstructing tissue. In these circumstances, another procedure may offer a more efficient and durable result.

When robotic simple prostatectomy may be preferred

Robotic simple prostatectomy is most often discussed for men with a very large prostate, marked obstruction, recurrent retention or complications such as bladder stones. It may also be considered when there is a large middle lobe protruding into the bladder or when previous endoscopic treatment has not provided enough relief.

The robotic approach gives the surgeon magnified three-dimensional vision and precise instrument control. This can facilitate removal of a large volume of adenoma and reconstruction of the urinary channel. For selected men, it offers a minimally invasive alternative to traditional open simple prostatectomy.

A hospital stay is commonly longer than after TURP, and a catheter may remain for several days while the surgical area heals. Recovery also involves temporary restrictions on strenuous activity and heavy lifting. Although small incisions are used, patients should understand that this is not a minor procedure.

The potential benefit is that a larger obstructing prostate can be treated comprehensively in one operation. As more adenoma is removed, the likelihood of needing repeat surgery for recurrent obstruction may be lower than with a limited resection. However, suitability must be assessed individually, and results depend on surgical findings and bladder health.

Comparing recovery, risks and expected outcomes

Both TURP and robotic simple prostatectomy are performed under anaesthesia and both require a period of catheter drainage. The recovery pathway differs because one is endoscopic and the other is abdominal surgery.

TURP generally has a shorter initial recovery, but urinary irritation can persist for several weeks as the resection area heals. Patients may notice urgency, frequency or a variable stream before improvement settles. Drinking adequate fluid, avoiding heavy exertion early in recovery and following catheter instructions are important.

Robotic simple prostatectomy can involve more postoperative discomfort in the first days due to the abdominal incisions and internal reconstruction. Recovery to usual activities may take several weeks. In exchange, it can be particularly effective where prostate size makes TURP less suitable.

Bleeding, infection, urinary retention, clot retention, urethral narrowing and bladder neck scarring are possible after either operation. The risk and type of complication vary with the procedure, prostate size, use of blood-thinning medication, other health conditions and previous surgery.

Changes to ejaculation are common after both procedures. Retrograde ejaculation occurs when semen passes backwards into the bladder rather than out through the penis during orgasm. This is not harmful, but it can affect fertility and should be discussed before treatment. Temporary urinary leakage can occur, particularly soon after catheter removal, while persistent incontinence is uncommon but remains a recognised risk.

Neither operation is intended to treat cancer. Tissue removed during surgery may be sent for laboratory assessment, and ongoing prostate monitoring may still be appropriate depending on age, PSA results, examination findings and family history.

Prostate size matters, but it is not the only factor

It is tempting to view the choice as simple: TURP for a smaller prostate and robotic simple prostatectomy for a larger one. In practice, the decision is more detailed. A man with a moderately enlarged prostate but poor bladder emptying may require a different discussion from someone with a very large prostate and strong bladder function.

The configuration of the prostate, particularly enlargement into the bladder, can influence procedural planning. So can bladder stones, a history of urinary retention, previous prostate procedures, anticoagulant medication, kidney function and anaesthetic risk. The availability of other techniques, such as laser enucleation, may also form part of a specialist discussion.

The most appropriate operation is therefore not necessarily the least invasive option in the short term. It is the procedure most likely to safely relieve obstruction and provide a durable improvement in urinary function for that individual.

Questions to discuss with your urologist

A useful consultation should clarify why surgery is being recommended and what the procedure is expected to achieve. Ask how large the prostate is, whether bladder function is likely to recover, how long the catheter may be required and what recovery restrictions apply.

It is also reasonable to ask about the surgeon’s experience with the proposed operation, the expected hospital stay, the likelihood of transfusion or further treatment, and how the procedure may affect ejaculation. For men from regional South Australia, planning for travel, catheter review and postoperative follow-up is an important part of the treatment pathway.

At Urology Health Adelaide, surgical planning is based on a detailed assessment of prostate anatomy, urinary symptoms and each patient’s broader health needs. A clear discussion of TURP, robotic simple prostatectomy and other suitable options allows treatment to be matched to the problem rather than forcing every patient into the same procedure.

Persistent urinary symptoms deserve specialist assessment, particularly when they interfere with sleep, work, travel or confidence. Timely review can identify whether medication remains appropriate or whether surgery offers a clearer path back to comfortable bladder emptying.

A weak stream, repeated night-time trips to the bathroom and the feeling that the bladder never fully empties can significantly affect daily life. When medication no longer provides adequate relief, the decision between TURP vs robotic simple prostatectomy usually comes down to the size and shape of the prostate, the degree of obstruction, overall health and the outcomes that matter most to the individual.

Both procedures treat urinary obstruction caused by benign prostatic enlargement, also called benign prostatic hyperplasia or BPH. They are not treatments for prostate cancer. The aim is to remove or reduce the obstructing inner part of the prostate so urine can pass more freely through the urethra.

Why an enlarged prostate can require surgery

The prostate sits below the bladder and surrounds the urethra, the tube that carries urine out of the body. As the prostate enlarges, it can narrow this passage and make bladder emptying more difficult. Symptoms may include a slow or interrupted stream, straining, urgency, frequency, nocturia, recurrent urinary infections or urinary retention.

Surgery may be considered when symptoms remain troublesome despite medication, when a man cannot pass urine without a catheter, or when obstruction is affecting bladder or kidney function. Bladder stones, recurrent visible bleeding in the urine and repeated urinary infections can also be reasons to discuss a procedure.

Before recommending surgery, a urologist assesses symptoms, urine flow, residual urine left in the bladder after voiding, prostate size and relevant blood tests. Imaging and cystoscopy may be required in selected cases. This evaluation is essential because similar urinary symptoms can have more than one cause.

TURP vs robotic simple prostatectomy: the key difference

A transurethral resection of the prostate, or TURP, is performed through the urethra. A narrow telescope is passed through the penis to the prostate, and the surgeon removes obstructing prostate tissue in small sections. There are no external surgical cuts. Modern TURP is commonly performed using bipolar energy, which allows tissue removal and control of bleeding with saline irrigation.

Robotic simple prostatectomy is a minimally invasive abdominal operation performed using robotic surgical instruments through several small incisions. The surgeon removes the enlarged inner portion of the prostate, often called the adenoma, while leaving the outer capsule in place. Despite the name, it is a major operation and is distinct from robotic radical prostatectomy, which removes the entire prostate for cancer treatment.

The central practical difference is the amount of tissue each operation is designed to address. TURP is a well-established option for many small to moderately enlarged prostates. Robotic simple prostatectomy is generally considered for substantially enlarged glands, particularly where a transurethral procedure may be less efficient or may need to be staged.

When TURP may be the appropriate procedure

TURP has been used for decades because it provides reliable relief of obstruction for appropriately selected men. It avoids abdominal incisions and is often suitable when the prostate is not excessively large. It can also be a sensible option for patients whose anatomy and health profile favour a shorter endoscopic operation.

After TURP, a urinary catheter is usually left in place temporarily to allow the bladder to drain and the urine to clear. Many patients stay in hospital overnight, although this varies according to recovery, bleeding and other medical considerations. Burning when passing urine, urinary frequency and small amounts of blood in the urine can occur during early healing.

TURP removes tissue from within the prostate but does not remove all prostate tissue. Symptoms commonly improve substantially, although the degree of improvement depends on bladder function as well as the obstruction itself. In some men, prostate tissue can regrow over time and further treatment may eventually be required.

For large prostates, TURP can take longer and may carry a higher risk of bleeding or incomplete removal of obstructing tissue. In these circumstances, another procedure may offer a more efficient and durable result.

When robotic simple prostatectomy may be preferred

Robotic simple prostatectomy is most often discussed for men with a very large prostate, marked obstruction, recurrent retention or complications such as bladder stones. It may also be considered when there is a large middle lobe protruding into the bladder or when previous endoscopic treatment has not provided enough relief.

The robotic approach gives the surgeon magnified three-dimensional vision and precise instrument control. This can facilitate removal of a large volume of adenoma and reconstruction of the urinary channel. For selected men, it offers a minimally invasive alternative to traditional open simple prostatectomy.

A hospital stay is commonly longer than after TURP, and a catheter may remain for several days while the surgical area heals. Recovery also involves temporary restrictions on strenuous activity and heavy lifting. Although small incisions are used, patients should understand that this is not a minor procedure.

The potential benefit is that a larger obstructing prostate can be treated comprehensively in one operation. As more adenoma is removed, the likelihood of needing repeat surgery for recurrent obstruction may be lower than with a limited resection. However, suitability must be assessed individually, and results depend on surgical findings and bladder health.

Comparing recovery, risks and expected outcomes

Both TURP and robotic simple prostatectomy are performed under anaesthesia and both require a period of catheter drainage. The recovery pathway differs because one is endoscopic and the other is abdominal surgery.

TURP generally has a shorter initial recovery, but urinary irritation can persist for several weeks as the resection area heals. Patients may notice urgency, frequency or a variable stream before improvement settles. Drinking adequate fluid, avoiding heavy exertion early in recovery and following catheter instructions are important.

Robotic simple prostatectomy can involve more postoperative discomfort in the first days due to the abdominal incisions and internal reconstruction. Recovery to usual activities may take several weeks. In exchange, it can be particularly effective where prostate size makes TURP less suitable.

Bleeding, infection, urinary retention, clot retention, urethral narrowing and bladder neck scarring are possible after either operation. The risk and type of complication vary with the procedure, prostate size, use of blood-thinning medication, other health conditions and previous surgery.

Changes to ejaculation are common after both procedures. Retrograde ejaculation occurs when semen passes backwards into the bladder rather than out through the penis during orgasm. This is not harmful, but it can affect fertility and should be discussed before treatment. Temporary urinary leakage can occur, particularly soon after catheter removal, while persistent incontinence is uncommon but remains a recognised risk.

Neither operation is intended to treat cancer. Tissue removed during surgery may be sent for laboratory assessment, and ongoing prostate monitoring may still be appropriate depending on age, PSA results, examination findings and family history.

Prostate size matters, but it is not the only factor

It is tempting to view the choice as simple: TURP for a smaller prostate and robotic simple prostatectomy for a larger one. In practice, the decision is more detailed. A man with a moderately enlarged prostate but poor bladder emptying may require a different discussion from someone with a very large prostate and strong bladder function.

The configuration of the prostate, particularly enlargement into the bladder, can influence procedural planning. So can bladder stones, a history of urinary retention, previous prostate procedures, anticoagulant medication, kidney function and anaesthetic risk. The availability of other techniques, such as laser enucleation, may also form part of a specialist discussion.

The most appropriate operation is therefore not necessarily the least invasive option in the short term. It is the procedure most likely to safely relieve obstruction and provide a durable improvement in urinary function for that individual.

Questions to discuss with your urologist

A useful consultation should clarify why surgery is being recommended and what the procedure is expected to achieve. Ask how large the prostate is, whether bladder function is likely to recover, how long the catheter may be required and what recovery restrictions apply.

It is also reasonable to ask about the surgeon’s experience with the proposed operation, the expected hospital stay, the likelihood of transfusion or further treatment, and how the procedure may affect ejaculation. For men from regional South Australia, planning for travel, catheter review and postoperative follow-up is an important part of the treatment pathway.

At Urology Health Adelaide, surgical planning is based on a detailed assessment of prostate anatomy, urinary symptoms and each patient’s broader health needs. A clear discussion of TURP, robotic simple prostatectomy and other suitable options allows treatment to be matched to the problem rather than forcing every patient into the same procedure.

Persistent urinary symptoms deserve specialist assessment, particularly when they interfere with sleep, work, travel or confidence. Timely review can identify whether medication remains appropriate or whether surgery offers a clearer path back to comfortable bladder emptying.

When urine cannot drain freely from the kidney to the bladder, the treatment must address the precise point of blockage. Pyeloplasty vs ureteric reimplantation is therefore not a choice between two interchangeable procedures. Each operation reconstructs a different section of the urinary tract and is used for different causes of obstruction or injury.

For adults, the decision is usually based on detailed imaging, kidney drainage and function, the length and location of any narrowing, previous treatment, and whether scarring, stones or another condition is contributing. A specialist urological assessment helps determine whether observation, endoscopic treatment or reconstructive surgery is most appropriate.

The anatomy behind the decision

The kidneys produce urine, which travels down narrow tubes called ureters into the bladder. At the top of each ureter is the ureteropelvic junction, or UPJ, where the kidney’s collecting system narrows to become the ureter. At the bottom, the ureter enters the bladder wall.

A blockage at the UPJ is treated differently from a blockage near the bladder. Pyeloplasty repairs the UPJ. Ureteric reimplantation repairs or bypasses a diseased lower section of ureter by creating a new connection between the ureter and bladder.

Both operations aim to preserve kidney drainage, reduce pain and infection risk, and protect long-term renal function. The reason for surgery, however, is as significant as the operation itself.

What is pyeloplasty?

Pyeloplasty is reconstructive surgery for obstruction at the UPJ. In adults, this may be due to a congenital narrowing that becomes symptomatic later in life, scar tissue, a crossing blood vessel affecting drainage, previous stone disease or prior surgery.

During a standard dismembered pyeloplasty, the narrowed portion of the UPJ is removed. The healthy ureter is then reconnected to the renal pelvis, which is the funnel-shaped part of the kidney that collects urine. If a crossing vessel is contributing to obstruction, the reconstruction can be positioned to avoid compression.

Symptoms can include intermittent flank pain, particularly after drinking large volumes of fluid, nausea, recurrent urinary tract infections, blood in the urine or kidney stones. Some people have few symptoms, with the issue identified on imaging performed for another reason. A dilated kidney on ultrasound does not automatically mean surgery is needed. The degree of drainage impairment and kidney function require proper assessment.

How pyeloplasty is performed

Pyeloplasty may be performed through open, laparoscopic or robotic-assisted surgery. For suitable patients, robotic surgery can provide a minimally invasive approach with precise suturing during reconstruction. The most appropriate technique depends on anatomy, prior operations, medical history and the treating surgeon’s assessment.

A temporary ureteric stent is commonly placed across the repair to support healing and ensure drainage. A catheter and, in some cases, a surgical drain may also be used for a short period after surgery. The stent is usually removed several weeks later during a planned procedure.

What is ureteric reimplantation?

Ureteric reimplantation is used when the problem affects the lower ureter, close to where it enters the bladder. The affected ureteric segment is removed or bypassed, and the remaining healthy ureter is implanted into a new site on the bladder.

In adults, reasons for reimplantation can include a ureteric stricture from previous surgery, inflammation, stone treatment, radiation therapy or injury. It may also be considered when disease outside the ureter causes narrowing or when a ureter has been damaged during pelvic surgery. In selected cases, it forms part of treatment for a condition affecting the bladder or lower urinary tract.

The surgeon needs enough healthy, mobile ureter to reach the bladder without tension. If the damaged segment is short, a direct reimplantation may be possible. When more length is required, the bladder can sometimes be mobilised towards the ureter using a psoas hitch. For a longer defect, a flap of bladder tissue, known as a Boari flap, may be used to bridge the gap. These decisions are made from the individual anatomy rather than a standard formula.

How reimplantation differs from pyeloplasty

The key difference is location. Pyeloplasty reconstructs the upper ureter at the kidney’s drainage outlet. Ureteric reimplantation reconstructs the lower ureter at its connection to the bladder.

This difference affects surgical planning. Pyeloplasty is focused around the kidney and upper abdomen. Reimplantation is generally performed in the pelvis and involves opening and repairing the bladder. A bladder catheter is therefore expected after ureteric reimplantation, often for longer than after pyeloplasty, depending on the repair performed.

Pyeloplasty vs ureteric reimplantation: how surgeons decide

The diagnosis should be clear before major reconstruction is considered. Investigations may include ultrasound, CT imaging, a nuclear renal scan to assess drainage and split kidney function, urine testing, and sometimes direct imaging of the ureter during a procedure. The results clarify not only where the obstruction lies, but whether it is functionally significant.

A patient with UPJ obstruction and preserved function may be monitored if symptoms are mild and imaging is stable. Surgery becomes more likely with persistent pain, recurrent infections, stones, worsening dilation or evidence that drainage or kidney function is deteriorating.

For a ureteric stricture, treatment depends on its cause, length and severity. A short, uncomplicated narrowing may sometimes be managed with a stent, dilation or incision from within the ureter. These less invasive options can be appropriate, but recurrence is possible, particularly with dense scar tissue or a longer stricture. Reimplantation is generally considered when a durable reconstruction is needed in the lower ureter.

Previous abdominal or pelvic surgery can influence the approach. So can prior radiation treatment, infection, body habitus, bladder capacity and the function of the affected kidney. The procedure selected must provide a well-vascularised, tension-free repair with reliable urine drainage.

Recovery and follow-up

Hospital stay and recovery vary with the surgical approach and complexity of reconstruction. Minimally invasive surgery may reduce incision size and assist early mobilisation, but it remains major reconstructive surgery. Fatigue, abdominal discomfort and reduced activity are common in the early weeks.

Patients are generally encouraged to walk regularly after surgery and to avoid strenuous exercise or heavy lifting until advised otherwise. Drinking adequate fluids is usually sensible unless a separate medical condition requires fluid restriction. Temporary urinary frequency, urgency or discomfort can occur while a ureteric stent is in place. Blood staining in the urine may also occur intermittently, especially after activity.

Follow-up is essential. The stent must be removed as scheduled, and imaging is often arranged after healing to assess drainage and kidney appearance. In some cases, a further renal scan is used to evaluate functional improvement or stability. Relief of pain is encouraging, but follow-up testing provides a more reliable assessment of surgical success.

Risks and realistic expectations

Both procedures carry general surgical risks, including bleeding, infection, blood clots, anaesthetic complications and injury to nearby structures. Specific risks include urine leak, stent-related symptoms, recurrent narrowing and the possible need for additional treatment.

With ureteric reimplantation, bladder-related issues such as a leak at the repair site or temporary irritative urinary symptoms may occur. With pyeloplasty, persistent or recurrent UPJ obstruction is uncommon but possible. A successful reconstruction improves drainage, but it may not resolve every symptom if pain has more than one cause or if kidney function was already significantly reduced.

Robotic and laparoscopic techniques are valuable options, particularly where fine reconstructive suturing is required. They do not replace careful case selection or follow-up. The expected benefit should be weighed against non-surgical alternatives and the natural history of the individual condition.

Preparing for specialist review

Bring any previous scan reports, operative records and a current medication list to your consultation. If you have experienced fever, severe flank pain, vomiting, reduced urine output or feel acutely unwell, seek urgent medical assessment, as an obstructed and infected kidney can require prompt drainage.

For planned treatment, the most useful question is not simply which operation is less invasive. It is which reconstruction best addresses the site and cause of the obstruction while protecting kidney function. A discussion with a specialist urologist can turn that answer into a clear, individual treatment plan.

A kidney mass is often found unexpectedly during a scan arranged for back pain, urinary symptoms, stones or another abdominal concern. A guide to kidney mass diagnosis should begin with this point: a mass is a finding, not a diagnosis. Some kidney masses are harmless cysts, while others require prompt investigation for possible kidney cancer. The purpose of assessment is to identify what the mass is, understand its behaviour and decide whether surveillance, treatment or further testing is appropriate.

What is a kidney mass?

A kidney mass is an area within or on the kidney that looks different from the surrounding tissue on imaging. It may be solid, fluid-filled, or contain both solid and cystic components. Size, location, appearance and contrast enhancement all help determine the likely cause.

Simple kidney cysts are common, particularly with increasing age. They contain clear fluid, have thin walls and usually require no treatment. More complex cysts may have internal partitions, calcium deposits, thickened walls or areas that enhance after contrast is given. These features need closer assessment because they can carry a variable risk of cancer.

Solid masses are assessed more carefully. Although not every solid lesion is cancerous, renal cell carcinoma is the most common primary cancer arising in the kidney. Other possibilities include benign growths such as oncocytoma or angiomyolipoma. Angiomyolipomas may contain visible fat on scans and, depending on their size and symptoms, can sometimes be monitored rather than removed.

Guide to kidney mass diagnosis: the first assessment

The diagnostic process usually starts with a detailed history, examination and review of the original imaging. Your urologist will ask about visible blood in the urine, flank pain, recurrent urinary infections, unexplained weight loss, fatigue and fever. Many people with a small kidney mass have no symptoms at all.

Relevant medical history includes kidney disease, high blood pressure, diabetes, smoking history, previous cancers and a family history of kidney tumours or inherited cancer syndromes. Existing kidney function is particularly important because it affects both imaging choices and treatment planning.

Blood and urine tests do not diagnose a kidney mass on their own, but they provide essential information. Blood tests commonly assess kidney function, including creatinine and estimated glomerular filtration rate, as well as full blood count and other baseline measures. Urine testing may identify blood, infection or protein. If blood is present in the urine, further assessment of the urinary tract may be needed, as the cause is not always the kidney mass itself.

Reviewing the scan

An ultrasound can detect a kidney lesion and distinguish many simple cysts from solid masses. However, ultrasound alone may not provide enough detail to characterise a suspicious lesion or plan treatment.

A contrast-enhanced CT scan of the kidneys is commonly used to define the mass. Images are taken at different times after contrast injection to assess whether the lesion enhances, which is a key feature in distinguishing solid tumours from cysts. CT also shows the relationship of the mass to blood vessels, the collecting system and nearby organs. It can assess the other kidney and identify enlarged lymph nodes or signs that disease has spread, where relevant.

MRI may be preferred when CT contrast is unsuitable, when radiation avoidance is desirable, or when the findings remain unclear. MRI can be especially useful for complex cysts, small lesions and tumours close to major vessels. In selected cases, contrast-enhanced ultrasound may also assist with characterisation.

The best scan is not simply the most detailed scan. It depends on kidney function, allergies, previous imaging and the question that needs to be answered. Comparing new images with older scans is valuable because the rate of growth can influence management.

Understanding cysts, solid lesions and scan findings

Radiologists use established imaging features to classify kidney lesions. For cystic masses, the Bosniak classification is often used to estimate the likelihood of malignancy and guide follow-up. A simple Bosniak I cyst is benign and needs no surveillance. More complex categories may need repeat imaging, specialist review or treatment, depending on the individual features.

For a solid kidney mass, enhancement with contrast raises concern for a tumour. However, scans cannot always determine the exact tumour type or grade. A small enhancing mass may be slow growing and suitable for active surveillance in some patients, while another lesion of similar size may be better treated because of its position, appearance, growth or the patient’s overall health.

Location matters. A small mass at the edge of the kidney may be suitable for partial nephrectomy, where the tumour is removed while preserving as much normal kidney tissue as possible. A larger or centrally positioned mass may require a different approach. These decisions are made from the imaging, kidney function and individual surgical risk, rather than size alone.

When is a kidney biopsy used?

A renal mass biopsy uses a fine needle, usually guided by CT or ultrasound, to obtain a tissue sample. It can help determine whether a lesion is benign or malignant and, if cancer is present, identify the tumour type. It is generally performed with local anaesthetic and may involve a short period of observation afterwards.

Biopsy is not required for every kidney mass. If imaging is strongly suggestive of a localised kidney cancer and surgery is already the preferred option, a biopsy may not change management. Conversely, biopsy can be particularly useful when active surveillance is being considered, when ablation is planned, when imaging is uncertain, or when the result could avoid unnecessary treatment.

Like all tests, biopsy has limitations. Occasionally, the sample is insufficient or does not fully represent a mixed tumour. There is also a small risk of bleeding, pain or infection. A specialist discussion should weigh whether the information gained is likely to change the treatment plan.

Assessing whether disease is localised

Where kidney cancer is suspected, staging determines whether the tumour appears confined to the kidney or has extended beyond it. CT imaging of the chest, abdomen and pelvis is often used for this purpose. Additional imaging may be recommended if symptoms or scan findings suggest a need to examine another area.

Most incidentally detected kidney masses are found at an early stage. This is one reason imaging review and timely urological assessment matter. Early-stage disease can often be managed with kidney-preserving surgery, minimally invasive surgery, surveillance or other targeted approaches, depending on the circumstances.

Choosing a management pathway

The result of a kidney mass assessment does not automatically lead to surgery. Management is individualised and should account for the nature of the lesion, its size and growth pattern, the condition of both kidneys, age, other health conditions and personal priorities.

Active surveillance involves planned repeat imaging to monitor a small mass. It may be appropriate for selected people with small lesions, significant competing health risks, limited kidney reserve or a lesion with a low-risk appearance. Surveillance is active management, not neglect. It requires a clear scan schedule and agreed triggers for reconsidering treatment.

For a mass requiring removal, partial nephrectomy is often considered where technically safe, particularly for small localised tumours. Preserving kidney tissue can reduce the risk of long-term loss of kidney function. Robotic and laparoscopic techniques can allow a minimally invasive approach in suitable cases, although open surgery remains the safer option for some more complex tumours.

Radical nephrectomy involves removal of the whole kidney and may be necessary when a mass is large, centrally located or cannot be safely removed with adequate remaining kidney tissue. Before recommending this approach, the surgeon assesses the function and condition of the other kidney carefully.

Ablative treatments, such as cryotherapy, may be an option for selected small lesions, particularly when surgery presents increased risk. They are not appropriate for every mass, and follow-up imaging is essential after treatment.

Preparing for your specialist appointment

Bring copies of all scan reports and, where possible, the actual imaging on disc or through the relevant imaging provider. A list of medicines, past operations, allergies and recent blood test results is also useful. Questions about the type of lesion, likelihood of cancer, need for biopsy, kidney-preserving options and expected follow-up are appropriate and should be addressed clearly.

At Urology Health Adelaide, kidney mass assessment is approached with careful review of imaging, kidney function and the full clinical picture. Where surgery is indicated, the suitability of minimally invasive and robotic techniques can be assessed alongside the priority of safe cancer treatment and kidney preservation.

A clear diagnosis may take more than one scan or test, particularly for small or complex lesions. The useful next step is a timely specialist review with the right images available, so decisions are based on the characteristics of your mass rather than uncertainty alone.

A blocked or damaged ureter can place ongoing pressure on the kidney, sometimes before symptoms become severe. This guide to ureteric reimplantation surgery explains how the procedure restores urine drainage, what surgery may involve, and the practical steps patients can expect before and after treatment.

The ureters are the narrow tubes that carry urine from each kidney to the bladder. When the lower section of a ureter is narrowed, injured or otherwise unable to drain effectively, a surgeon may need to disconnect the affected section and create a new connection between the ureter and bladder. This is called ureteric reimplantation.

When ureteric reimplantation is considered

Ureteric reimplantation is generally recommended when a problem in the lower ureter cannot be safely or reliably managed with observation, medication, a stent, or a less extensive endoscopic procedure. The aim is to protect kidney function, relieve obstruction and reduce the risk of recurrent infection or pain.

In adults, common reasons include a ureteric stricture, injury to the ureter during previous pelvic or abdominal surgery, scarring from stone disease or prior treatment, or obstruction associated with a tumour. In some cases, the ureter has been affected by radiotherapy or significant inflammation. The precise cause matters because it influences the surgical plan, the complexity of reconstruction and the outlook after treatment.

Symptoms can include flank pain, recurrent urinary tract infections, fever, blood in the urine or changes in kidney function. However, obstruction is sometimes found on imaging performed for another reason. A patient can have substantial blockage with few symptoms, which is why scans and kidney function tests are central to assessment.

Assessment before surgery

A specialist urological assessment determines whether reimplantation is appropriate and whether there is enough healthy ureter to reach the bladder without tension. A tension-free connection is one of the key principles of successful reconstruction.

Investigations may include blood tests to assess kidney function, urine testing to identify or exclude infection, and imaging such as CT, ultrasound or a nuclear renal scan. Imaging defines where the blockage is, its length and the condition of the affected kidney. Some patients will also require a cystoscopy, where a small camera is used to inspect the bladder and the opening of the ureter.

If a ureter is significantly obstructed, temporary drainage may be needed before definitive surgery. This can involve a ureteric stent placed internally or a nephrostomy tube that drains the kidney through the back. These measures do not necessarily replace surgery, but they can relieve pressure on the kidney while the reconstruction is planned.

Your surgeon will review previous operations, radiotherapy, stone procedures and medical conditions that may affect anaesthesia or healing. Bring an up-to-date medication list to your consultation, particularly if you take anticoagulants, antiplatelet medicines or medication for diabetes.

How ureteric reimplantation surgery is performed

The operation is performed under general anaesthesia. The surgeon accesses the bladder and affected ureter, removes or bypasses the diseased segment where necessary, and reattaches the healthy ureter to the bladder. The new connection is designed to provide unobstructed drainage and, where appropriate, reduce the chance of urine travelling backwards towards the kidney.

The approach may be open, laparoscopic or robotic. The right technique depends on the location and length of the ureteric problem, the degree of scarring, previous surgery, body habitus and whether another procedure is being performed at the same time. Robotic surgery can provide magnified three-dimensional vision and fine instrument control during reconstructive work in the pelvis. It is not automatically suitable for every case, and an open operation remains the safest option in some complex situations.

When additional reconstruction is needed

A short lower-ureter defect may be repaired by directly joining the ureter to the bladder. If more length is required, the bladder can sometimes be gently mobilised and secured closer to the pelvic side wall, known as a psoas hitch. For a longer defect, a flap of bladder tissue may be fashioned into a tube to bridge the distance. This is called a Boari flap.

These are established reconstructive techniques, but they involve different trade-offs. More extensive reconstruction may provide a durable solution for a longer stricture, while also requiring a longer operation and a more involved recovery. The condition and capacity of the bladder, prior treatment and the remaining healthy ureter all guide this decision.

A temporary internal ureteric stent is commonly placed across the new join to support healing and keep the ureter open. A bladder catheter is also left in place at the end of surgery. Depending on the operation, a surgical drain may be used for a short period.

Hospital stay and early recovery

The length of hospital stay varies with the surgical approach, the extent of reconstruction and individual recovery. Patients undergoing minimally invasive surgery may mobilise and return to a light diet earlier, although this does not mean recovery is immediate. Open surgery usually involves a larger incision and may require a longer stay.

The bladder catheter commonly remains in place for a period after discharge. Before it is removed, your surgeon may arrange imaging to confirm that the bladder repair has healed appropriately. The ureteric stent is generally removed later, often during a brief procedure. Your treating team will provide a specific timetable for catheter care, stent removal and follow-up.

While the catheter or stent is in place, patients may notice bladder discomfort, urinary urgency, frequency, pink-tinged urine or discomfort in the kidney area during urination. These symptoms can be troublesome but are often temporary. Severe pain, fever, chills, worsening bleeding, inability to drain the catheter or feeling generally unwell should be reported promptly.

Most patients need to avoid heavy lifting, strenuous exercise and driving while taking strong pain relief or while movement is restricted. The timing of return to work depends on the type of work and the operation performed. Desk-based duties may be possible sooner than physically demanding work. Your surgeon can give advice that reflects your procedure and recovery progress.

Risks and expected outcomes

Every operation carries risks, including bleeding, infection, blood clots, pain and complications related to anaesthesia. Specific risks of ureteric reimplantation include urine leakage from the new connection, recurrent narrowing or obstruction, injury to nearby structures, ongoing urinary symptoms, and the need for further procedures.

There is also a possibility that kidney drainage or kidney function may not fully recover, particularly if obstruction has been longstanding. Surgery can prevent further damage and improve drainage, but it cannot always reverse pre-existing kidney injury. This is one reason timely specialist assessment is valuable.

The overall outlook is often favourable when the cause of obstruction can be addressed and the reconstruction heals well. Follow-up is an essential part of care. It may include symptom review, blood tests and imaging to confirm that urine drains freely and the kidney remains stable.

Questions to discuss with your surgeon

Before proceeding, it is reasonable to ask why reimplantation is recommended in your case, whether robotic, laparoscopic or open surgery is most appropriate, and whether a psoas hitch or bladder flap may be required. Ask how long you are likely to have a catheter and stent, when you can return to work and driving, and what follow-up imaging will be arranged.

It is also useful to discuss the expected effect on your kidney function, particularly if you have reduced function in either kidney or have had previous stone, cancer or pelvic surgery. Clear planning before the operation helps patients prepare for recovery at home and recognise when they should contact their treating team.

Ureteric reconstruction is highly individual: the best approach is the one that safely restores drainage while preserving kidney function and fitting the anatomy of the problem. A detailed consultation with an experienced urological surgeon is the right place to turn the scan findings into a clear treatment plan.

A cystoscopy allows a urologist to examine the urethra and bladder directly, rather than relying only on scans or urine tests. If you are wondering what happens during cystoscopy, the procedure is usually brief and well tolerated, but the experience differs depending on why it is being performed and whether a flexible or rigid cystoscope is required.

Cystoscopy may be recommended to investigate blood in the urine, recurrent urinary tract infections, bladder symptoms, urethral narrowing, bladder stones or an abnormality seen on imaging. It may also be used to monitor the bladder after previous treatment, remove or take a sample of tissue, or place and remove a ureteric stent.

Why a cystoscopy is performed

The bladder lining and urethra cannot always be assessed fully with ultrasound, CT imaging or urine testing. A cystoscopy gives the urologist a direct view of these structures. This can help identify inflammation, stones, an enlarged prostate causing obstruction, a urethral stricture, bladder tumours or other causes of urinary symptoms.

A normal cystoscopy can also be valuable. It may rule out significant bladder or urethral disease and help direct further investigation or treatment. The reason for the procedure should be discussed at your consultation, including what the result may mean for your care.

Before your cystoscopy

Preparation depends on the type of cystoscopy planned. A flexible cystoscopy is commonly performed in a procedure room using local anaesthetic gel. In many cases, you can eat and drink normally beforehand and return home shortly afterwards.

A rigid cystoscopy, or a procedure involving a biopsy, stone treatment, stent work or another intervention, is generally undertaken in hospital under general anaesthetic or spinal anaesthetic. You will be given fasting instructions beforehand and will need someone to drive you home. Do not drive, operate machinery, make major decisions or drink alcohol for 24 hours after a general anaesthetic.

Tell your urologist about blood-thinning medicines, diabetes medications, allergies, previous urine infections and any difficulty passing urine. Do not stop prescribed anticoagulant or antiplatelet medication unless you have been specifically advised to do so. In some circumstances, a urine test is arranged before the procedure to check for infection. An active urinary infection may need treatment before cystoscopy proceeds.

What happens during flexible cystoscopy?

For a flexible cystoscopy, you will usually be asked to empty your bladder, change into a gown and lie comfortably on an examination couch. The genital area is cleaned, and local anaesthetic lubricating gel is inserted into the urethra. The gel reduces discomfort and helps the cystoscope pass smoothly.

The flexible cystoscope is a narrow, bendable instrument with a light and camera at its tip. It is passed gently through the urethra into the bladder. Sterile fluid is introduced to fill the bladder enough for the lining to be examined clearly. You may feel a cool sensation, pressure in the lower abdomen, or an urge to pass urine as the bladder fills.

The urologist examines the urethra, prostate region in men, bladder neck and bladder lining. The camera images are viewed on a monitor. A straightforward diagnostic flexible cystoscopy commonly takes only a few minutes, although your appointment may be longer to allow for preparation and discussion of findings.

Most people describe the procedure as uncomfortable rather than painful. Passing the scope through the external urinary opening and the sensation of bladder filling are often the least comfortable parts. Slow breathing and trying to relax the pelvic floor can make the procedure easier.

When a rigid cystoscopy is needed

Rigid cystoscopy uses a straight telescope and is commonly performed in an operating theatre. It is useful when the urologist needs to perform treatment as well as inspection. This may include taking a bladder biopsy, removing a bladder stone, treating a bladder lesion, dilating a urethral narrowing or placing a stent into the ureter.

Because it is usually performed with an anaesthetic, you will not feel the procedure itself. The duration varies considerably. A simple examination may be short, while a procedure involving biopsy or treatment takes longer and may require observation in hospital afterwards.

Following some rigid procedures, a urinary catheter may be left in place temporarily. This drains urine from the bladder while swelling or bleeding settles. Your treating team will explain whether a catheter is expected, how long it may be needed and what arrangements apply for its removal.

After cystoscopy: common short-term symptoms

After a flexible cystoscopy, most patients can go home soon after the procedure. It is common to notice mild burning when passing urine, temporary urinary frequency, or a small amount of blood in the urine for a day or two. Drinking extra water, unless you have been advised to restrict fluids for another medical reason, can help flush the bladder and reduce irritation.

After a rigid cystoscopy or biopsy, blood in the urine may be more noticeable initially. Small clots can occur, particularly after bladder treatment. Your urologist will provide procedure-specific instructions about activity, work, exercise and when to restart medications. These instructions take priority over general advice because recovery depends on exactly what was done.

If local anaesthetic gel alone was used, you can generally resume normal activities when you feel comfortable. If you received sedation, spinal anaesthetic or general anaesthetic, arrange for a responsible adult to take you home and follow the hospital’s discharge advice.

Risks and when to seek medical advice

Cystoscopy is a commonly performed urological procedure, but no procedure is without risk. The more extensive the treatment performed, the more individualised the risk discussion needs to be.

Possible complications include a urinary tract infection, bleeding, difficulty passing urine due to swelling or clots, and temporary discomfort. Less commonly, there may be injury to the urethra or bladder. The risk of complications can be influenced by factors such as prostate enlargement, a known urethral stricture, prior surgery, infection, blood-thinning medication and whether a biopsy or other treatment is required.

Contact your urology team or seek urgent medical assessment if you develop fever or chills, worsening pain, heavy bleeding or large blood clots, are unable to pass urine, or feel significantly unwell. These symptoms can indicate infection, urinary retention or bleeding that requires prompt review. If you cannot reach your treating team and symptoms are severe, attend an emergency department.

Understanding your results

In many diagnostic cystoscopies, the urologist can explain the visual findings immediately. If tissue has been removed, laboratory analysis is required and results are not available on the day. The timing of follow-up depends on the reason for the procedure and whether further treatment, imaging or monitoring is needed.

It is reasonable to ask what was seen, whether a biopsy was taken, whether any restrictions apply, and who to contact if symptoms do not settle. At Urology Health Adelaide, cystoscopy findings are considered alongside your symptoms, urine tests, imaging and broader medical history to guide an appropriate management plan.

A cystoscopy is often a short step in a much larger diagnostic pathway, but it can provide information that scans and tests cannot. Knowing the purpose of your procedure, the type of cystoscopy planned and the symptoms that need review can help you attend with confidence and recover safely.